Senti Biosciences Holdings

SNTI

Market cap $12.9M

SNTI Hedge Fund Activity: Q1 2026 in Review

16 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q1 2026, worth a combined $4.58M — down 22% from $5.84M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SNTI positions and 4 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $60.2K. The largest seller was Virtu Financial, exiting entirely with an estimated $46K sold.

• 16 institutional investors held Senti Biosciences Holdings (SNTI) as of Q1 2026, up from 15 in Q4 2025.
• Funds reported $4.58M of Senti Biosciences Holdings stock for Q1 2026, down 22% quarter-over-quarter.
• 7 funds opened new Senti Biosciences Holdings positions in Q1 2026 and 4 closed out, a net change of +3 holders.
• The largest Senti Biosciences Holdings buyer in Q1 2026 was Geode Capital Management, an estimated $60.2K added.
• The largest Senti Biosciences Holdings seller in Q1 2026 was Virtu Financial, an estimated $46K sold.

Based on aggregated 13F filings for Q1 2026.